Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Kala Pharmaceuticals Inc (NQ: KALA )

0.3614 -0.0192 (-5.04%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 24, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,040,210
Open 0.3850
Bid (Size) 0.3651 (20)
Ask (Size) 0.3800 (62)
Prev. Close 0.3806
Today's Range 0.3614 - 0.3908
52wk Range 0.3400 - 6.110
Shares Outstanding 72,594,005
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Stocks That Hit 52-Week Lows On Tuesday
On Tuesday, 36 companies achieved new lows for the year. 
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
During Friday's session, 59 stocks hit new 52-week lows. 
Via Benzinga

Performance

YTD
-73.62%
-73.62%
1 Month
-23.93%
-23.93%
3 Month
-78.23%
-78.23%
6 Month
-73.43%
-73.43%
1 Year
-93.88%
-93.88%

More News

Read More
Recap: Kala Pharmaceuticals Q1 Earnings
Via Benzinga
Earnings Scheduled For May 16, 2022
Via Benzinga
Kala Pharmaceuticals Posts KPI-012 Data In Healing Impaired Ocular Diseases
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
88 Biggest Movers From Yesterday
Via Benzinga
Recap: Kala Pharmaceuticals Q4 Earnings
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Kala Pharmaceuticals Shares Are Rising Today
Via Benzinga
71 Biggest Movers From Yesterday
Via Benzinga
This Biopharma Stock Surges After Offloading Its Ophthalmic Eye Drop Portfolio
Via Benzinga
50 Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
What 4 Analyst Ratings Have To Say About Kala Pharmaceuticals
Via Benzinga
The Week Ahead In Biotech: Gene & Cell Therapy Conference, Tapering Earnings News, OKYO Pharma IPO And More
Via Benzinga
Earnings Preview For Kala Pharmaceuticals
Via Benzinga
66 Biggest Movers From Yesterday
Via Benzinga
AI Pharma Startup METiS Raises $150 Million. IPO In Sight?
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2022
Via Benzinga
53 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
The Daily Biotech Pulse: Sanofi-IGM Ink Antibody Drug Collaboration; NeoGenomics Sinks On CEO Departure, Q1 Warning; Decision Day For Akebia
Via Benzinga
Earnings Scheduled For March 29, 2022
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.